UK Markets closed

Global Migraine Drugs Markets, 2018-2019 & 2020-2026: Macro Indicator Analysis, Therapeutic Class, Treatment Type, Competitive Landscape

Research and Markets
·4-min read

Dublin, Feb. 10, 2021 (GLOBE NEWSWIRE) -- The "Migraine Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global migraine drugs market to grow with a CAGR of 8.38% % over the forecast period from 2020-2026.

The report on the global migraine drugs market provides qualitative and quantitative analysis for the period from 2018 to 2026. The study on the migraine drugs market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2018 to 2026.

The report on the migraine drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global migraine drugs market over the period of 2018 to 2026. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global migraine drugs market over the period of 2018 to 2026. Further, the Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

What does this Report Deliver?

  • Comprehensive analysis of the global as well as regional markets of the migraine drugs market.

  • Complete coverage of all the segments in the migraine drugs market to analyze the trends, developments in the global market and forecast of market size up to 2026.

  • Comprehensive analysis of the companies operating in the global migraine drugs market. The company profile includes analysis of product portfolio, revenue, SWOT analysis, and the latest developments of the company.

  • Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand, and/or diversify.

Report Findings

1) Drivers

  • The Growing Awareness Regarding Migraine and Numerous Options Available for its Treatment

2) Restraints

  • Adverse Effects of Drugs

3) Opportunities

  • Number of Vendors are Planning to Invest in the Migraine Drugs R&D

Key Topics Covered:

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Migraine Drugs Market Highlights
2.2. Migraine Drugs Market Projection
2.3. Migraine Drugs Market Regional Highlights

3. Global Migraine Drugs Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 impact on the Migraine Drugs Market
3.4. Porter's Five Forces Analysis
3.5. Growth Matrix Analysis
3.5.1. Growth Matrix Analysis by Therapeutic Class
3.5.2. Growth Matrix Analysis by Treatment Type
3.5.3. Growth Matrix Analysis by Region
3.6. Value Chain Analysis of Migraine Drugs Market

4. Migraine Drugs Market Macro Indicator Analysis

5. Global Migraine Drugs Market by Therapeutic Class
5.1. Ergot
5.2. Triptans
5.3. Others

6. Global Migraine Drugs Market by Treatment Type
6.1. Abortive
6.2. Abortive Preventive

7. Global Migraine Drugs Market by Region 2020-2026
7.1. North America
7.1.1. North America Migraine Drugs Market by Therapeutic Class
7.1.2. North America Migraine Drugs Market by Treatment Type
7.1.3. North America Migraine Drugs Market by Country
7.2. Europe
7.2.1. Europe Migraine Drugs Market by Therapeutic Class
7.2.2. Europe Migraine Drugs Market by Treatment Type
7.2.3. Europe Migraine Drugs Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Migraine Drugs Market by Therapeutic Class
7.3.2. Asia-Pacific Migraine Drugs Market by Treatment Type
7.3.3. Asia-Pacific Migraine Drugs Market by Country
7.4. RoW
7.4.1. RoW Migraine Drugs Market by Therapeutic Class
7.4.2. RoW Migraine Drugs Market by Treatment Type
7.4.3. RoW Migraine Drugs Market by Sub-region

8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Migraine Drugs Market
8.2. Companies Profiled
8.2.1. GlaxoSmithKline PLC
8.2.2. Amgen Inc.
8.2.3. ALLERGAN PLC
8.2.4. ELI LILY & Company
8.2.5. Merck KGaA
8.2.6. Amneal Pharmaceuticals Inc.
8.2.7. H. Lundbeck A/S
8.2.8. Neurelis Inc.
8.2.9. Pfizer Inc.
8.2.10. Zogenix, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/hytjnu

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900